Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Sep 2026 and Oct 2026.
- Largest single sale: $486K (2,000 shares) of Jazz Pharmaceuticals plc on Sep 8, 2026. Filing
- Last sale before this period: May 18, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | President & CEO, Director | May 11, 2020 | Oct 7, 2026 |
| Dexcom (DXCM) | Director | Mar 10, 2025 | Jun 1, 2026 |
| Corcept Therapeutics Inc (CORT) | Former Director | Jun 28, 2016 | Aug 22, 2018 |
Also a director at
Dexcom (DXCM), Corcept Therapeutics Inc (CORT) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 6, 2026, Jazz Pharmaceuticals plc: sold 2,000 shares for $473K, under a disclosed plan. 1 filing: 1
- Sep 8, 2026, Jazz Pharmaceuticals plc: sold 2,000 shares for $486K, under a disclosed plan; 1,967 shares withheld by the company for taxes. 1 filing: 1
- Jun 30, 2026, Jazz Pharmaceuticals plc: 4,835 shares withheld by the company for taxes. 1 filing: 1
- Jun 3, 2026, Jazz Pharmaceuticals plc: 600 shares given away. 1 filing: 1
- May 28, 2026, Dexcom: 5,605 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.